经皮冠状动脉介入治疗急性心肌梗死合并心源性休克患者的疗效观察.docVIP

经皮冠状动脉介入治疗急性心肌梗死合并心源性休克患者的疗效观察 　　[摘要] 目的 研究分析经皮冠状动脉介入治疗急性心肌梗死合并心源性休克患者的疗效。方法 选择2011年1月～2013年6月收治的急性心肌梗死合并心源性休克的70例患者为研究对象，将其分为实验组和对照组，各35例。实验组患者使用经皮冠状动脉介入治疗，对照组患者使用药物治疗，观察比较两组平均住院时间、血管开通率、心功能恢复情况及病死率。结果 治疗后在平均住院时间及病死率方面，实验组均明显少于对照组（P0.05），而在血管开通率及心功能恢复情况方面，实验组均高于对照组（P0.05）。结论 经皮冠状动脉介入治疗急性心肌梗死合并心源性休克，较药物治疗住院时间少，血管开通率高，心功能恢复好，病死率低，安全有效，可作为治疗首选方案。 　　[关键词] 经皮冠状动脉；急性心肌梗死；心源性休克 　　[中图分类号] R542.22 [文献标识码] B [文章编号] 1673-9701（2014）23-0132-03 　　[Abstract] Objective To study and analyze the curative effect on acute myocardial infarction patients combined cardiac shock by percutaneous coronary intervention. Methods All 70 cases acute myocardial infarction patients combined cardiac shock treated from January 2011 to June 2013 were chosen as the research objects. They were divided into the experiment group and the control group， 35 cases in each group. The experiment group patients were treated by percutaneous coronary intervention， the control group patients were treated by drugs. The average length of hospital stay， blood vessels reperfusion rate， cardiac function recovery and case fatality rate of two groups were compared. Results After the treatment，the average hospitalization time and mortality rate of the experimental group were significantly less than that of the control group（P0.05）， and the patency rate and heart function of the experiment group was significantly higher than that of control group（P0.05）. Conclusion The curative effect on percutaneous coronary intervention for acute myocardial infarction complicated with cardiogenic shock is sure，it is better than that treated by drugs， the mortality rate is low， safe and effective，it can be used as the treatment of choice. 　　[Key words] Percutaneous coronary intervention；Acute myocardial infarction；Cardiogenic shock 　　据报道，急性心肌梗死（AMI）合并心源性休克是心肌梗死患者死亡的最主要原因[1]。患者发生急性心肌梗死后，如果心脏左心室损伤面积逐渐增加达40%以上时，心脏泵血将受到严重损害，继而发生泵衰竭，发展为心源性休克[2]。治疗方法一般使用药物及基本治疗，但统计发现该治疗方法患者病死率高，并且虽然可以减少心源性休克发生率，但是一旦发生，患者会发生循环功能障碍。近几年发现，使用经皮冠状动脉介入治疗（P